HEAD & NECK CANCER
Clinical trials for HEAD & NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD & NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD & NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise against tonsil cancer
Disease control Recruiting nowThis study tests whether giving a combination of three drugs (nimotuzumab, toripalimab, and chemotherapy) before surgery can shrink advanced tonsil cancer and improve outcomes. Ten adults with resectable tonsil cancer will receive the treatment and then have surgery. The main goa…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New hope for head and neck cancer patients who Can't take chemo
Disease control Recruiting nowThis phase 3 trial tests a new treatment for high-risk head and neck cancer patients who cannot receive the standard chemotherapy drug cisplatin. After surgery, patients get radiation therapy combined with nimotuzumab (a targeted drug) followed by benmelstobart (an immunotherapy)…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE3 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC
-
New weekly combo offers hope for head and neck cancer patients who can't take standard chemo
Disease control Recruiting nowThis study is for people with advanced head and neck cancer that has spread and cannot be treated with surgery or radiation. It tests a weekly combination of two chemotherapy drugs (carboplatin and paclitaxel) plus an immunotherapy drug (pembrolizumab) in patients who cannot take…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New combo therapy offers hope for head and neck cancer patients who Can't take chemo
Disease control Recruiting nowThis study tests whether adding the targeted drug nimotuzumab to standard radiation therapy helps people with advanced head and neck cancer live longer without the cancer growing or spreading. It is for patients who cannot receive platinum-based chemotherapy. About 335 adults wil…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE3 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New combo therapy targets hard-to-treat head and neck cancers
Disease control Recruiting nowThis study tests a new drug (RiMO-301) given with targeted radiation and an immunotherapy drug (a PD-1 inhibitor) for people with advanced head and neck cancer that cannot be removed by surgery or has spread. The goal is to find a safe dose and see if the combination can shrink t…
Matched conditions: HEAD & NECK CANCER
Phase: PHASE1, PHASE2 • Sponsor: Coordination Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
Sound waves target cancer pain without surgery
Symptom relief Recruiting nowThis early-stage study tests a new way to treat severe pain from head, neck, and brachial cancers when opioids no longer help. Using MRI-guided focused ultrasound, doctors create a small lesion in the brain's pain pathway to block pain signals. The study involves 20 adults aged 1…
Matched conditions: HEAD & NECK CANCER
Phase: NA • Sponsor: University of Virginia • Aim: Symptom relief
Last updated Apr 29, 2026 15:01 UTC